TARGET AUDIENCE
This course is intended primarily for Nephrology & Hypertension Physicians, fellows, NPs, PAs, and Nurses.

LEARNING OBJECTIVES
Upon completion of this activity, participants should be able to:
1) Practice with a more nuanced understanding of the clinical evaluation and management of patients with hypertension and kidney diseases through review of cases that specifically emphasize issues related to renal imaging, renal biopsy/pathology, hypertension, renal replacement therapy, and electrolytes-acid/base disorders on a rotating basis.
2) Practice with a more advanced understanding of a wide range of important topics in the field of hypertension and renal diseases. 
3) Critically evaluate nephrology research publications. Recognize cutting-edge developments in the evaluation and management of kidney diseases and the strength of evidence that support these developments. 

ACCREDITATION STATEMENT

In support of improving patient care, Mayo Clinic College of Medicine and Science is jointly accredited by the Accreditation Council for Continuing Medical Education (ACCME), the Accreditation Council for Pharmacy Education (ACPE), and the American Nurses Credentialing Center (ANCC) to provide continuing education for the healthcare team.

Credit Statement(s):
AMA

Mayo Clinic College of Medicine and Science designates this live activity for a maximum of 1.0 AMA PRA Category 1 Credits^TM. Physicians should claim only the credit commensurate with the extent of their participation in the activity.

Disclosure Summary
As a provider accredited by Joint Accreditation Interprofessional Continuing Education, Mayo Clinic College of Medicine and Science (Mayo Clinic School of CPD) must ensure balance, independence, objectivity and scientific rigor in its educational activities. Course Director(s), Planning Committee Members, Faculty, and all others who are in a position to control the content of this educational activity are required to disclose all relevant financial relationships with any commercial interest related to the subject matter of the educational activity.  Safeguards against commercial bias have been put in place.  Faculty also will disclose any off label and/or investigational use of pharmaceuticals or instruments discussed in their presentation.  Disclosure of these relevant financial relationships will be published in activity materials so those participants in the activity may formulate their own judgments regarding the presentation.

Listed below are individuals with control of the content of this program who have disclosed...

Relevent financial relationship(s) with industry: 
None

No relevent financial relationship(s) with industry: 
Nabeel Aslam, MD; Emma Bueno, MD; Peter Fitzpatrick, MD; Patricia Lewis; Ivan Porter, II, MD; Kara Smith; Christopher Trautman, MD

For disclosure information regarding Mayo Clinic School of Continuous Professional Development accreditation review committee member(s), please go here. 

ATTENDANCE/CREDIT
Text the session code (provided only at the session) to 507-200-3010 within 48 hours of the live presentation to record attendance.  All learners are encouraged to text attendance regardless of credit needs.  This number is only used for receiving text messages related to tracking attendance.  Additional tasks to obtain credit may be required based on the specific activity requirements and will be announced accordingly. Swiping your badge will not provide credit; that process is only applicable to meet GME requirements for Residents & Fellows. 

COURSE DIRECTORS
Nabeel Aslam, MD; Peter Fitzpatrick, MD

QUESTIONS?
Contact Patricia Lewis at ph. 3-6302 or Kara Smith at ph. 3-7259.